03869 弘和仁愛醫療
按盘价 
6.650 -0.010 (-0.150%) 盈利能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 资产回报率 (%) | -1.520% | 5.326% | -17.303% | -8.175% | -9.863% |
| 股东资金回报率 (%) | -10.778% | 41.394% | -91.289% | -29.892% | -31.549% |
| 资本运用回报率 (%) | -5.002% | 15.724% | -74.011% | -10.806% | -12.391% |
边际利润分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 毛利率 (%) | 19.124% | 16.765% | 13.201% | 41.175% | 48.678% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 16.985% | 13.760% | -41.534% | -75.713% | -89.410% |
| 税前边际利润率 (%) | 4.248% | 15.143% | -46.601% | -86.318% | -109.170% |
| 纯利率 (%) | -2.678% | 9.202% | -42.079% | -53.952% | -101.285% |
变现能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 流动比率 (X) | 0.607 X | 0.572 X | 0.472 X | 2.235 X | 2.631 X |
| 速动比率 (X) | 0.590 X | 0.541 X | 0.440 X | 2.144 X | 2.617 X |
财务杠杆分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 总负债 / 总资产比率 (%) | 77.714% | 76.334% | 81.794% | 63.639% | 63.484% |
| 总债项 / 总资产比率 (%) | 44.605% | 41.202% | 45.312% | 37.507% | 45.160% |
| 净债项 / 总资产比率 (%) | 16.960% | 20.265% | 24.904% | 23.407% | 22.172% |
| 总债项 / 股东资金比率 (%) | 341.188% | 271.508% | 431.584% | 146.823% | 156.542% |
| 长期债项 / 股东资金比率 (%) | 2.118% | 1.909% | 2.440% | 125.344% | 147.509% |
| 净债项 / 股东资金比率 (%) | 129.729% | 133.540% | 237.199% | 91.630% | 76.857% |
| 净现金 / (债项) ($) | (4.38亿) | (5.06亿) | (6.07亿) | (7.31亿) | (8.30亿) |
| 每股净现金 / (债项) ($) | (3.170) | (3.663) | (4.389) | (5.291) | (6.007) |
| 总债项 / 资本运用比率 (%) | 149.196% | 123.186% | 169.828% | 45.102% | 51.819% |
| 利息盈利率 (X) | -- | -- | N/A | N/A | N/A |
营运效率分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 存货周转率日数 (日) | 12.915日 | 16.661日 | 19.334日 | 32.553日 | 10.316日 |
| 应收贸易帐周转率日数 (日) | 33.521日 | 26.229日 | 29.753日 | 52.173日 | 29.384日 |
| 应付贸易帐周转率日数 (日) | 38.681日 | 36.737日 | 41.700日 | 49.480日 | 13.754日 |
| 备注： | 实时报价更新时间为16/05/2025 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
